| 4.3°C Dublin

Close

Premium

Explainer: Amid supply issues and fresh delays, where do we stand in the scramble for vaccines?

With unprecedented global demand and issues sourcing raw materials, fewer people than hoped will get the jab in the coming weeks

Close

The European Union’s row with AstraZeneca and the recent decision by Italy to block the export of 250,000 doses to Australia show how high the stakes are. Photo: Linh Pham/Getty Images

The European Union’s row with AstraZeneca and the recent decision by Italy to block the export of 250,000 doses to Australia show how high the stakes are. Photo: Linh Pham/Getty Images

The European Union’s row with AstraZeneca and the recent decision by Italy to block the export of 250,000 doses to Australia show how high the stakes are. Photo: Linh Pham/Getty Images

It’s the reality we cannot wish away.

Covid-19 vaccine manufacturers look set to continue to disappoint with smaller or stalled deliveries at various points in the coming months, and targets for inoculating the population will need to be rewritten.


Most Watched





Privacy